Priority 3 from the Idiopathic Intracranial Hypertension PSP

UNCERTAINTY: Can new therapies for IIH be developed which are effective, safe, and tolerable and potentially help with weight loss as well as reducing brain pressure? (JLA PSP Priority 3)
Overall ranking 3
JLA question ID 0066/3
Explanatory note Not available for this PSP
Evidence

None identified
Health Research Classification System category Neurological
Extra information provided by this PSP
Original uncertainty examples Are further drugs in development for treatment of papilloedema? ~ What are the alternatives to diamox to treat IIH? ~ What are the best evidence based non-medical interventions for treatment of IIH?
Submitted by See data spreadsheet on JLA website
PSP information
PSP unique ID 0066
PSP name Idiopathic Intracranial Hypertension
Total number of uncertainties identified by this PSP. 48  (To see a full list of all uncertainties identified, please see the detailed spreadsheet held on the JLA website)
Date of priority setting workshop 27 April 2018